NCT00006877 Temozolomide in Treating Patients With Metastatic Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00006474 Temozolomide and O6-benzylguanine in Treating Patients With Newly Diagnosed, Recurrent, or Progressive Anaplastic Glioma Status COMPLETED Phase PHASE1
NCT00006358 Temozolomide Plus Thalidomide in Treating Patients With Recurrent or Progressive Brain Tumor Status COMPLETED Phase PHASE2
NCT00006353 Radiation Therapy With or Without Temozolomide in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Status COMPLETED Phase PHASE3
NCT00006263 Carboplatin, Temozolomide, and Filgrastim in Treating Patients With Newly Diagnosed or Recurrent High-Grade Glioma Status WITHDRAWN Phase PHASE2
NCT00006043 Temozolomide in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to Cisplatin Status COMPLETED Phase PHASE2
NCT00006025 Temozolomide Plus Irinotecan in Treating Patients With Recurrent Malignant Glioma Status COMPLETED Phase PHASE1
NCT00006024 Temozolomide Plus Lomustine Followed by Radiation Therapy in Treating Patients With High-Grade Malignant Glioma Status COMPLETED Phase PHASE1
NCT00005955 Temozolomide Followed by Radiation Therapy in Treating Children With Newly Diagnosed Malignant CNS Tumors Status COMPLETED Phase PHASE2
NCT00005952 Temozolomide Plus Peripheral Stem Cell Transplantation in Treating Children With Newly Diagnosed Malignant Glioma or Recurrent CNS or Other Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT00005951 Irinotecan Plus Temozolomide in Treating Patients With Recurrent Primary Malignant Glioma Status COMPLETED Phase PHASE1
NCT00005815 Temozolomide and Thalidomide in Treating Patients With Stage III or Stage IV Melanoma Status COMPLETED Phase PHASE1/PHASE2
NCT00005812 Temozolomide in Treating Patients With Leptomeningeal Metastases From a Solid Tumor or Lymphoma Status TERMINATED Phase PHASE2
NCT00005637 Combination Chemotherapy Following Radiation Therapy in Treating Patients With Malignant Glioma Status COMPLETED Phase PHASE1
NCT00005597 S9926 Temozolomide in Patients With Unresectable/Metastatic Gastrointestinal Stromal Tumors Status COMPLETED Phase PHASE2
NCT00005037 Temozolomide in Treating Patients With Stage IIIB, Stage IV, or Recurrent Non-small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00004204 Temozolomide in Treating Patients With Recurrent or Progressive Malignant Glioma Status UNKNOWN Phase PHASE2
NCT00004200 Prinomastat Plus Temozolomide Following Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme Status COMPLETED Phase PHASE2